Spesolimab: A Review of the First IL-36 Blocker Approved for Generalized Pustular Psoriasis.

Gaurav Nitin PathakEmily WangJimmy DhillonPrachi N ParikhReem EsseghirBabar K RaoSteven Richard Feldman

Published in: The Annals of pharmacotherapy (2024)

Spesolimab is a safe and effective treatment for acute GPP flares in adults. Future clinical trials can establish safety and efficacy compared with other agents.

Keyphrases

clinical trial
liver failure
current status
randomized controlled trial
aortic dissection
intensive care unit
hepatitis b virus
angiotensin converting enzyme
replacement therapy
study protocol
double blind
mechanical ventilation